Mangalam Drugs

MANGALAM28 Mar 2024
Pharmaceuticals
-1.40 (-1.50%)
Lowest Today
Highest Today
Today’s Open
Prev. Close
52 Week High
52 Week Low
To Invest in Mangalam Drugs
Mangalam Drugs
Pharmaceuticals
MANGALAM28 Mar 2024
-1.40 (-1.50%)
OverviewFundamentals
1D
1M
6M
1Y
5Y
All

Mangalam Drugs - Share Price & Details

Lowest Today
90.8
Highest Today
96.5
Today’s Open
93.05
Prev. Close
93.5
52 Week High
132.45
52 Week Low
90.8
Traded Volume
Market Cap(Cr)
Avg Traded Price
1 Year return
-4.81%
Upper Circuit
Lower Circuit
P/E TTM
0
P/B Ratio
1.06
Traded Value(Cr)
0.00
EPS TTM
0
Book value
Dividend
0.00%

Price Performance

-6.02 %
1 Wk
-23.70 %
1 M
-6.07 %
3 M
-4.81 %
1 Y
-7.44 %
YTD

Traded Volume Movement

Technical Details

Support 3
85
Support 2
88
Support 1
90
Pivot Point :
94
Resistance 1
96
Resistance 2
99
Resistance 3
102

Peer Comparison

Scrip NamePriceDaily ChangeM.Cap (Cr)1 Year Returns %P/E (TTM)PB Ratio
Mangalam Drugs and Organics Ltd
₹92.10(-1.40/-1.50%)
92.10-1.40145.78-4.810.001.06
Lupin Ltd
₹1,616.80(+16.85/1.05%)
1,616.80+16.8573,665.75150.9035.773.82
J B Chemicals & Pharmaceuticals Ltd
₹1,650.40(+7.50/0.46%)
1,650.40+7.5025,613.3568.3950.579.54
Ipca Laboratories Ltd
₹1,237.40(+32.10/2.66%)
1,237.40+32.1031,393.3656.3357.065.06
Sanofi India Ltd
₹8,113.95(+153.15/1.92%)
8,113.95+153.1518,686.4344.1831.6618.41
361.45+0.652,121.9130.1812.301.34

About Mangalam Drugs and Organics Ltd

Mangalam Drugs and Organics Ltd is in the Pharmaceuticals sector, having a market capitalization of Rs. 146.65 crores. It has reported a sales of Rs. 97.05 crores and a net profit of Rs. 0.5 crores for the quarter ended December 2018. The company management includes Govardhan M Dhoot, Govardhan M Dhoot,Brijmohan Dhoot,Rukmesh P. Dhandhania,Nidhi S. Mundada,Praveen Saxena,Jayant Barde,Rakesh K. Milwani (Mangalam Drugs and Organics Ltd) among others.
Chairman
Govardhan M Dhoot
Registered office
3rd Floor Rupam Building,239 P D Mello Road,Mumbai,Maharashtra,400001
FAX :91-22-26190900
Background
Incorporation Year1972
Face Value₹10
Market Lot1

Latest News

Short-term picks: Three stocks that may generate 17-25% returns
The Nifty 50 index has consistently displayed a bullish price structure, characterised by higher top, higher bottom formations, and is hovering near its all-time high levels on the monthly charts, indicating a strong positive sentiment for the long term. Recently, the index found significant support at the 13-week EMA (exponential moving average) and formed a notable Bullish Opening.
29 Mar 2024 | 10:01 AM
Short-term picks: Three stocks that may generate 17-25% returns
The Nifty 50 index has consistently displayed a bullish price structure, characterised by higher top, higher bottom formations, and is hovering near its all-time high levels on the monthly charts, indicating a strong positive sentiment for the long term. Recently, the index found significant support at the 13-week EMA (exponential moving average) and formed a notable Bullish Opening.
29 Mar 2024 | 10:01 AM
Tata boom! Love-all-things-Tata portfolio soars by over Rs 9 lakh crore
Dalal Street's love for all-things-Tata got deeper in FY24 with 9 stocks, including the newly-listed Tata Technologies, giving multibagger returns up to 257%. Even the worst performing Tata stock gave 11% return.The combined market capitalisation of all Tata stocks (excluding Tata Tech) rose by Rs 9.15 lakh crore to Rs 29.62 lakh crore. This turns out into a profit of nearly 45%.
29 Mar 2024 | 10:46 AM
A modest debut for T+0 settlement
Mumbai: India launched its same-day settlement cycle for stock market trades, popularly known as T+0, on March 28 in a pilot programme that saw limited participation among investors and traders.According to BSE, 63 brokers participated in the shorter trade settlement process with 41 trading in 10 stocks. They placed a total of 329 orders which resulted in 90 trades, said the exchange in a release.
29 Mar 2024 | 10:28 AM
Tatas keeping a close eye on pledged shares
The Tata Trusts and Tata Sons are said to be closely monitoring the Shapoorji Pallonji (SP) Group's bid to raise ₹20,000 crore from state-run institutions to refinance debt taken against stakes in the Tata Group holding company. The Mistry family-promoted SP Group holds an 18.37% stake in Tata Sons, all of which is pledged against loans.
29 Mar 2024 | 10:25 AM

How to buy Mangalam Drugs shares on nse?

To buy Mangalam Drugs shares in Motilal Oswal, you just need to open a demat account and get your KYC documents verified

What is the Mangalam Drugs share price today?

The Mangalam Drugs shares price on nse is Rs.92.1 today.

What is the market cap of Mangalam Drugs shares on NSE ?

The company has a market capitalization of Rs.145.78Cr

What is the PE & PB ratio of Mangalam Drugs shares ?

PE is 0 and PB is 1.06

What is the 52 Week High and Low of Mangalam Drugs shares?

Mangalam Drugs stock price high: Rs.132.45 Mangalam Drugs stock price low: Rs.90.8
setTimeout(function() { }, 5000);